Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

fludarabine phosphate 26Cyclophosphamide 25Peripheral Blood Stem Cell Transplantation 24Mycophenolic Acid 20Tacrolimus 17Cyclosporine 17Busulfan 16Antilymphocyte Serum 13Filgrastim 12Methotrexate 11Radiotherapy 9Whole-Body Irradiation 8Melphalan 8Etoposide 8Sirolimus 7Methylprednisolone 7Cord Blood Stem Cell Transplantation 7Flow Cytometry 6Cyclosporins 6Psychiatric Rehabilitation 5Polymerase Chain Reaction 4Alemtuzumab 4Rituximab 3Immunologic Techniques 3Immunoenzyme Techniques 3Early Intervention, Educational 3Doxorubicin 3Cytarabine 3thymoglobulin 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × Baclofen × Plasma cell × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡